New Cancer Specific Targets & Antibodies
New Hope in Cancer Therapy
Our Oncotope Platform rapidly identifies multiple cancer specific targets and simultaneously generates therapeutic antibodies against these targets.
Novel Therapeutic
Discovery Platform
ABOUT ONCOTOPE
- Cancer is a global health emergency. Unfortunately, virtually all treatments that kill cancer cells adversely affect normal healthy cells, causing debilitating side effects.
- Targeted immunotherapy is the leading approach for combating cancer. A key challenge has been to identify cancer-specific antigens that are suitable for antibody-based therapeutics.
- The market for cancer immunotherapies is substantial, exemplified by recent sales of two different antibodies targeting a single antigen, TROP-2, on Triple Negative Breast Cancer, which reached a staggering $27 billion.
- Our cutting-edge Oncotope Platform has revolutionized the discovery of cancer-specific antigens. Remarkably, it can identify multiple new antigens on any cancer type in a matter of months.